Literature DB >> 3942547

Parafoveal telangiectasis and diabetic retinopathy.

E Y Chew, R P Murphy, D A Newsome, S L Fine.   

Abstract

Five patients with mild nonproliferative diabetic retinopathy had visual loss associated with parafoveal telangiectasis. Minimal macular edema with characteristic parafoveal plaques of subretinal pigment epithelial hyperplasia was seen in all patients. Fluorescein angiography revealed the presence of ectatic, dilated, leaking perifoveal capillaries. The occurrence of parafoveal telangiectasis in patients with diabetic retinopathy has, to our knowledge, not been previously described. One previous clinicopathologic report described the histologic appearance of parafoveal telangiectasis in a nondiabetic patient to be similar to that seen in diabetic patients. The association of parafoveal telangiectasis and diabetic retinopathy raises interesting speculations into the pathogenesis of the entity of parafoveal telangiectasis. In addition, the importance of obtaining fluorescein angiography prior to therapy of diabetic macular edema is emphasized.

Entities:  

Mesh:

Year:  1986        PMID: 3942547     DOI: 10.1001/archopht.1986.01050130081025

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Authors:  Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo
Journal:  Nat Genet       Date:  2017-02-27       Impact factor: 38.330

2.  The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.

Authors:  Ronald Klein; Barbara A Blodi; Stacy M Meuer; Chelsea E Myers; Emily Y Chew; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2010-07       Impact factor: 5.258

3.  Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2.

Authors:  Joshua A Szental; Paul N Baird; Andrea J Richardson; F M Amirul Islam; Hendrik P N Scholl; Peter Charbel Issa; Frank G Holz; Mark Gillies; Robyn H Guymer
Journal:  Int Ophthalmol       Date:  2010-05-25       Impact factor: 2.031

4.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 5.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

6.  Familial asymptomatic macular telangiectasia type 2.

Authors:  Mark C Gillies; Meidong Zhu; Emily Chew; Daniel Barthelmes; Edward Hughes; Haipha Ali; Frank G Holz; Hendrik P N Scholl; Peter Charbel Issa
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

7.  Comparison of macular pigment in three types of macular telangiectasia.

Authors:  Miki Sawa; Fumi Gomi; Chikako Ueno; Mihoko Suzuki; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-12       Impact factor: 3.117

8.  Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.

Authors:  Traci E Clemons; Marc C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria J Figueroa; Molly W Harrington
Journal:  Ophthalmic Epidemiol       Date:  2010 Jan-Feb       Impact factor: 1.648

9.  Apelin is required for non-neovascular remodeling in the retina.

Authors:  Jenny A G McKenzie; Marcus Fruttiger; Sabu Abraham; Clemens A K Lange; Jay Stone; Pranita Gandhi; Xiaomeng Wang; James Bainbridge; Stephen E Moss; John Greenwood
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

10.  Identification of a potential susceptibility locus for macular telangiectasia type 2.

Authors:  Nancy L Parmalee; Carl Schubert; Maria Figueroa; Alan C Bird; Tunde Peto; Mark C Gillies; Paul S Bernstein; Krzysztof Kiryluk; Joseph D Terwilliger; Rando Allikmets
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.